{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-022880","form_type":"8-K","ticker":"BKYI","cik":"0001019034","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2026-07-07T12:45:22+00:00","discovered_at":"2026-07-07T12:50:26.570069+00:00","generated_at":"2026-07-07T12:50:43.331627+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BIO-key regains Nasdaq compliance; trading resumes July 8 after hearing panel decision","bullets":["Nasdaq Hearings Panel determined BIO-key regained compliance with minimum bid price and SEC filing requirements.","Trading of BKYI common stock resumes on Nasdaq Capital Market on July 8, 2026.","Company subject to Discretionary Panel Monitor for one year until July 6, 2027.","CEO cites growing recurring revenue, solid financial position, and expects significantly improved results in 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-022880","json":"https://secwatch.observer/filing/0001437749-26-022880.json","markdown":"https://secwatch.observer/filing/0001437749-26-022880.md","text":"https://secwatch.observer/filing/0001437749-26-022880.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926022880/0001437749-26-022880-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926022880/bkyi20260706c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-07T12:50:43.331627+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}